Obstetrics & Gynecology Doctors in Dansville, NY Accepting Medicare

4 Obstetrics & Gynecology doctors found. Showing 1 - 4

Teresita Gungon, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 253 Main St, Dansville, NY 14437 Phone: 585-335-2296    Fax: 585-335-2299

Robert Bonvino, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 253 Main St, Dansville, NY 14437 Phone: 585-335-2296    Fax: 585-335-2299

Linda D Meehan, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 111 Clara Barton St, Dansville, NY 14437 Phone: 585-335-2296

Zenaida Roque, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 253 Main St, Dansville, NY 14437 Phone: 585-335-2296    Fax: 585-335-2299

News Archive

MCG receives $1.8M stimulus grant

It's a $1.8 million shot in the arm to the largest grant the Medical College of Georgia has ever received.

Guide to solvent evaporation

Solvent removal covers a broad range of applications where it is necessary to remove or concentrate a solvent from a solution.

Biological scientists lead major research project that aims to make drugs more effective

University of Southampton biological scientists are leading a major research project aimed at making drugs more effective.

PBS Newshour shares stories of those affected by HIV/AIDS epidemic

"As Washington prepares to host the International AIDS Conference from July 22-27, PBS NewsHour will profile some of the parallel stories unfolding around the epidemic on opposite ends of the globe," the news service writes. In the first of these stories, the news service profiles two individuals - John Johnson in Washington, D.C., and Alice Sibanda in Hwange, Zimbabwe - who as children lost their parents to the HIV/AIDS epidemic.

Preclinical data of dual TLR7 and TLR8 agonist in cancer published

Idera Pharmaceuticals, Inc. today announced the publication of data from studies of a dual agonist of Toll-like Receptor 7 and TLR8 in preclinical models of cancer. The Company created this first-in-class RNA-based dual agonist of TLR7 and TLR8 through its chemistry-based approach to identifying novel TLR-targeted drug candidates.

Read more Medical News

› Verified 4 days ago